Acute Pancreatitis News and Research

RSS
Acute pancreatitis is a sudden inflammation of the pancreas. Depending on its severity, it can have severe complications and high mortality despite treatment. While mild cases are often successfully treated with conservative measures, such as NPO (nil by mouth or NBM) and IV fluid rehydration, severe cases may require admission to the ICU or even surgery (often requiring more than one intervention) to deal with complications of the disease process.
Phase 3 study: Tapentadol ER lowers incidence of gastrointestinal adverse events

Phase 3 study: Tapentadol ER lowers incidence of gastrointestinal adverse events

FDA approves Purdue's Butrans Transdermal System CIII for management of chronic pain

FDA approves Purdue's Butrans Transdermal System CIII for management of chronic pain

Amylin presents improved indices of beta-cell function after three years of BYETTA(R) therapy

Amylin presents improved indices of beta-cell function after three years of BYETTA(R) therapy

First placebo-controlled clinical study results of BYETTA injection with Lantus presented at ADA 2010

First placebo-controlled clinical study results of BYETTA injection with Lantus presented at ADA 2010

JANUMET results in greater blood sugar reductions in patients with type 2 diabetes compared to pioglitazone

JANUMET results in greater blood sugar reductions in patients with type 2 diabetes compared to pioglitazone

Data on BYETTA and SYMLIN injections, BYDUREON drug candidate to be presented at ADA 2010

Data on BYETTA and SYMLIN injections, BYDUREON drug candidate to be presented at ADA 2010

DURATION-4 study tests superiority of BYDUREON as compared to other type 2 diabetes medications

DURATION-4 study tests superiority of BYDUREON as compared to other type 2 diabetes medications

Data comparing NUCYNTA to oxycodone IR for osteoarthritis pain presented at 29th APS

Data comparing NUCYNTA to oxycodone IR for osteoarthritis pain presented at 29th APS

Severe and necrotizing AP characterized by depletion of circulating lymphocytes

Severe and necrotizing AP characterized by depletion of circulating lymphocytes

NDA for BYDUREON: FDA issues complete response letter

NDA for BYDUREON: FDA issues complete response letter

Study reveals molecular mechanism of pancreatic cancer

Study reveals molecular mechanism of pancreatic cancer

Hundred millions for biotech-licence

Hundred millions for biotech-licence

FDA approves Victoza to treat type 2 diabetes in some adults

FDA approves Victoza to treat type 2 diabetes in some adults

Positive results from study comparing exenatide once weekly to BYETTA

Positive results from study comparing exenatide once weekly to BYETTA

Study finds better than predicted outcomes for patients who undergo pancreatic necrosectomy

Study finds better than predicted outcomes for patients who undergo pancreatic necrosectomy

AMT inks agreement with Progenika Biopharma for development of LPLchip

AMT inks agreement with Progenika Biopharma for development of LPLchip

Repligen completes patient treatment in its Phase 3 RG1068 clinical trial

Repligen completes patient treatment in its Phase 3 RG1068 clinical trial

Early detection of PGAP may reduce mortality rate

Early detection of PGAP may reduce mortality rate

Safety profiles of JANUVIA and JANUMET drugs established through clinical development program

Safety profiles of JANUVIA and JANUMET drugs established through clinical development program

Amsterdam Molecular Therapeutics reports 2009 half year financials

Amsterdam Molecular Therapeutics reports 2009 half year financials